A systematic review was conducted with the MEDLINE database using the search phrase “BRCA2 prostate” [12].
Sample text:```Our results confi rm previous studies that reached the same conclusion (Boushey et al 1994; Vermeulen et al 2000; Till et al 2005; Marcucci et al 2005).```
Sample intent: result
Sample text:```Therefore, one manifestation of the BRCA1–TONSL genetic interaction may well operate at sites of UV-induced damage, where both proteins are normally engaged in complex DNA damage responses (Duro et al. 2010; O’Connell et al. 2010; O’Donnell et al. 2010; Piwko et al. 2010; Pathania et al. 2011).```
Sample intent: method



Sample text:```Cisplatin has dramatically been used as the first line treatment for several types of solid tumors, such as breast, head and neck, ovarian, and lung cancers [17].```
Sample intent: method



Sample text:```Results from a RCT assessing in-person post-test genomic counseling on 199 OSU-CMPC participants were published previously [18].```
Sample intent: method



Sample text:```We used longitudinal sequence samples for 15 patients from two independent studies [13,22].```
Sample intent: background



Sample text:```In line with our results, several previous studies demonstrated the anti-proliferative effect of PPARs agonists in several cell types [11-15].```
Sample intent: result
Sample text:```In men, two studies [36, 43], indicated that obesity was associated with lower CRC screening rates.```
Sample intent: result



Sample text:```Estimation of overall mortality ratio (relative risk) was carried out using the random e ects model according to DerSimonian and Laird [9].```
Sample intent: background



Sample text:```Eight of the included studies examined the history of changes made to each registry record in order to compare published outcomes with the primary outcome as stated in the registry at either the time of study initiation or prior to completion of enrollment [7, 16, 20, 22, 24, 30, 31, 36].```
Sample intent: result



Sample text:```In line with our results, several previous studies demonstrated the anti-proliferative effect of PPARs agonists in several cell types [11-15].```
Sample intent: result



Sample text:```Lee et al. (2001) Human lung squamous cell carcinoma (CH27), human lung nonsmall cell carcinoma (H460) CH27 and H460 cells were treated with aloeemodin or emodin.```
Sample intent: method



Sample text:```Our results confi rm previous studies that reached the same conclusion (Boushey et al 1994; Vermeulen et al 2000; Till et al 2005; Marcucci et al 2005).```
Sample intent: result



Sample text:```Results from a RCT assessing in-person post-test genomic counseling on 199 OSU-CMPC participants were published previously [18].```
Sample intent: method



Sample text:```Only one published paper (Enock et al. 2014) has examined this question, and thatwas in the context of anABM training study.```
Sample intent: method



Sample text:```Cisplatin has dramatically been used as the first line treatment for several types of solid tumors, such as breast, head and neck, ovarian, and lung cancers [17].```
Sample intent: method



Sample text:```This study supports the theory of a tumor origin from multipotential progenitor cells.(14) Reports of the Ki67 labeling index have demonstrated great variety.```
Sample intent: result